<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-t001" target="_blank">Table 1</a> shows the demographics of the patient cohort.</p>a<p>Refers to the patients included, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-g001" target="_blank">figure 1</a>.</p>b<p>Age (in years) refers to age at sampling time point. <sup>c</sup>Mean number of attacks, refers to attacks before sampling time point.</p>d<p>Disease duration (in months) refers to period from debut of first symptom(s) to sampling time point.</p>e<p>Time since last attack, refers to the period (days = d or years = y) from latest attack to sampling time point. Abbreviations: RRMS (relapsing-remit...
<p>Data are expressed as mean ± standard deviation. AMS: multiple sclerosis patients during disease ...
<p>PP = progressive-relapsing multiple sclerosis; RR = relapsing-remitting multiple sclerosis; SP = ...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p>Table 2 shows the demographics and clinical data of the patient cohort. These demographic and cli...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>RRMS: recurrent-remittent MS; SPMS: secondary-progressive MS; CIS: clinically isolated syndrome.<...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-t003" ...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F =...
<p>Data are expressed as median and range (in brackets). There were no statistically significant dif...
<p>These patients had the classic characteristics of MS populations: F/M sex ratio 2.47 (19,656/7,94...
<p>CIS all = all patients with CIS, CIS-CIS = patients with CIS that remained CIS over follow-up...
Objectives: To explore whether time to diagnosis, time to treatment initiation and age to reach disa...
<p>CIS, clinical isolated syndrome; EDSS, Expanded Disability Status Scale; MS, multiple sclerosis; ...
The mechanisms leading to disability and the long-term efficacy and safety of disease modifying drug...
<p>Data are expressed as mean ± standard deviation. AMS: multiple sclerosis patients during disease ...
<p>PP = progressive-relapsing multiple sclerosis; RR = relapsing-remitting multiple sclerosis; SP = ...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...
<p>Table 2 shows the demographics and clinical data of the patient cohort. These demographic and cli...
a<p>Age (in years) refers to age at sampling time point.</p>b<p>Disease duration (in years) refers t...
<p>RRMS: recurrent-remittent MS; SPMS: secondary-progressive MS; CIS: clinically isolated syndrome.<...
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0098588#pone-0098588-t003" ...
<p>Values for age, MS disease duration, EDSS and EDSS change are medians with interquartile ranges i...
<p>Note: - = no data; BPF = brain parenchymal fraction; EDSS = expanded disability status scale; F =...
<p>Data are expressed as median and range (in brackets). There were no statistically significant dif...
<p>These patients had the classic characteristics of MS populations: F/M sex ratio 2.47 (19,656/7,94...
<p>CIS all = all patients with CIS, CIS-CIS = patients with CIS that remained CIS over follow-up...
Objectives: To explore whether time to diagnosis, time to treatment initiation and age to reach disa...
<p>CIS, clinical isolated syndrome; EDSS, Expanded Disability Status Scale; MS, multiple sclerosis; ...
The mechanisms leading to disability and the long-term efficacy and safety of disease modifying drug...
<p>Data are expressed as mean ± standard deviation. AMS: multiple sclerosis patients during disease ...
<p>PP = progressive-relapsing multiple sclerosis; RR = relapsing-remitting multiple sclerosis; SP = ...
<p><sup>*</sup>P-values (crude) were calculated from analysis of variance (ANOVA), α = 0.05.</p><p><...